Cargando…
The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
INTRODUCTION: Transarterial chemoembolization (TACE) is the commonly used therapy of unresectable hepatocellular carcinoma (HCC), though the prognosis of different TACE-treated HCC patients varies, which may be due to the heterogeneity of HCC tumors caused by genetic variants and epigenetic changes...
Autores principales: | Zeng, Jiajia, Han, Linyu, Wang, Teng, Huang, Linying, Zheng, Yanxiu, Zhang, Nasha, Li, Ziqiang, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032144/ https://www.ncbi.nlm.nih.gov/pubmed/36970122 http://dx.doi.org/10.2147/PGPM.S402115 |
Ejemplares similares
-
Integrative Functional Genomics Implicated the Key T-/B-Cell Deficiency Regulator RAG1 in Transarterial Chemoembolization of Hepatocellular Carcinoma
por: Xu, Yeyang, et al.
Publicado: (2021) -
Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Ahmed, Saleem, et al.
Publicado: (2016) -
Case-control study of ADARB1 and ADARB2 gene variants in migraine
por: Gasparini, Claudia F, et al.
Publicado: (2015) -
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015) -
Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)